Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

NSE/THYROCARE stock hub

NSE/THYROCARE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/THYROCAREis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

77.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/THYROCARE

In the news

Latest news · NSE/THYROCARE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E40.7

P25 24.9P50 32.4P75 45.7

Trailing P/E56.2

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC35.3

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/THYROCARE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

INR

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,822
Employees Change	129%
Employees Change Percent	7.62
Enterprise value	INR 75.6B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	INE594H01019
Last refreshed	2026-05-10
Market cap	INR 77.3B
Price	INR 486
Price currency	INR
Rev Per Employee	4,348,243.69x
Sector	Healthcare
Sic	8071
Symbol	nse/THYROCARE
Website	https://www.thyrocare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.78%
EV Earnings	54.98x
EV/EBIT	40.51x
EV/EBITDA	30.57x
EV/Sales	9.54x
Forward P/E	40.73x
P/B ratio	14.47x
P/E ratio	56.2x
P/S ratio	9.75x
PE Ratio10 Y	42.72x
PE Ratio3 Y	46.84x
PE Ratio5 Y	42.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.53%
EBITDA Margin	30.12%
Gross margin	53.06%
Gross Profit	INR 4.2B
Gross Profit Growth	29.52%
Gross Profit Growth Q	31.4%
Gross Profit Growth3 Y	18.66%
Gross Profit Growth5 Y	11.7%
Net Income	INR 1.4B
Net Income Growth	56.69%
Net Income Growth Q	51.81%
Net Income Growth Quarters	11%
Net Income Growth Years	3%
Net Income Growth3 Y	23.42%
Net Income Growth5 Y	13.17%
Pretax Margin	24.68%
Profit Margin	17.35%
Profit Per Employee	INR 754,555
Profitable Years	16
Roa5y	13.81
Roe5y	21.5
ROIC	35.28
Roic5y	25.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	61.51%
Cagr3y	49.74%
Cagr5y	8.97%
Div CAGR3	15.87%
Div CAGR5	2.29%
EPS Growth	59.68
EPS Growth Q	52.52
EPS Growth Years	0
EPS Growth3 Y	23.91
EPS Growth5 Y	13.39
Revenue Growth	21.06x
Revenue Growth Q	17.85x
Revenue Growth Quarters	14x
Revenue Growth Years	3x
Revenue Growth3 Y	14.97x
Revenue Growth5 Y	11.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.9B
Debt	INR 246.8M
Debt EBITDA	INR 0.1
Debt Equity	INR 0.05
Equity	INR 5.3B
Interest Coverage	93.21
Net Cash	INR 1.7B
Net Cash By Market Cap	INR 2.17
Net Cash Growth	40.94%
Net Debt EBITDA	INR -0.7
Net Debt Equity	INR -0.31
Tangible Book Value	INR 4.2B
Tangible Book Value Per Share	INR 26.53
WACC	6.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.87%
Dividend Growth	55.56%
Dividend Growth Years	1%
Dividend per share	INR 9.33
Dividend Years	10
Dividend Yield	2.02%
Ex Div Date	2025-10-24
Last Dividend	INR 2.33
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	61.46%
200-day SMA	425
3Y total return	235.81%
50-day SMA	389.7
50-day SMA vs 200-day SMA	50under200
5Y total return	53.61%
All Time High	536.7
All Time High Change	-9.44%
All Time High Date	2025-11-18
All Time Low	135.7
All Time Low Change	258.1%
All Time Low Date	2019-07-31
ATR	20.18
Beta	0.35
Ch YTD	9.04
High	526
High52	536.7
High52 Date	2025-11-18
High52ch	-9.44%
Low	478
Low52	291.4
Low52 Date	2025-06-06
Low52ch	66.8%
Ma50ch	24.7%
Price vs 200-day SMA	14.35%
RSI	81.01
RSI Monthly	62.8
RSI Weekly	64.24
Sharpe ratio	1.38x
Sortino ratio	2.34
Total Return	3.89%
Tr YTD	9.04
Tr1m	28.32%
Tr1w	15.6%
Tr3m	19.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.9B
Operating Income Growth	64.66
Operating Income Growth Q	46.74
Operating Income Growth3 Y	25.03
Operating Income Growth5 Y	9.02
Operating margin	23.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,009,265%
Shares Insiders	0.12%
Shares Institutions	21.98%
Shares Qo Q	0.53%
Shares Yo Y	-1.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	828,590.35x
Bv Per Share	33.6
Ch1m	28.32
Ch1w	15.6
Ch1y	58.03
Ch3m	19.81
Ch3y	222
Ch5y	37.62
Ch6m	4.81
Change	3.25%
Change From Open	-1.42
Close	470.7
Days Gap	4.74
Depreciation Amortization	522,325,000
Dollar Volume	5,307,888,366
Earnings Date	2026-05-07
EBIT	INR 1.9B
EBITDA	INR 2.4B
EPS	INR 8.75
F Score	2
Fiscal Year End	March
Founded	1,996
Graham Number	80.84808
Graham Upside	-83.36
Income Tax	INR 599.2M
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2025-12-31
Last Split Date	2025-11-28
Last Split Type	Forward
Lynch Fair Value	INR 114
Lynch Upside	-76.57
Ma150	424.5
Ma150ch	14.5%
Ma20	411.6
Ma20ch	18.07%
Open	493
Payment Date	2025-11-13
Position In Range	16.67
Price Date	2026-05-08
Price EBITDA	INR 32.38
Ptbv Ratio	18.32
Relative Volume	17.35x
Revenue	7,922,500,000x
Tax By Revenue	7.56x
Tax Rate	30.65%
Tr6m	4.81%
Volume	10,921,581

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/THYROCARE dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$9.33 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.3%

1 consecutive years of growth

Total shareholder yield

+3.9%

Next ex-dividend date: 2025-10-24

Performance

NSE/THYROCARE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/THYROCARE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.9%

Negative means the company is buying back shares.

Technical

NSE/THYROCARE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

81.0

Above 70: short-term overbought

Price vs 200-day MA

+14.4%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/THYROCARE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/THYROCARE stock rating?

nse/THYROCARE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/THYROCARE analysis?

The full report lives at /stocks/nse/THYROCARE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/THYROCARE?

The latest report frames nse/THYROCARE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/THYROCARE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.